Digital and Paper-Based Hospital Workflows and 60-Day Mortality in Acute Leukemia: A Natural Experiment From Mexico
ABSTRACT
Background:
Acute leukemias pose a significant challenge in Latin America, where social, biological, and infrastructural barriers lead to poorer outcomes compared to developed countries. These include a higher prevalence of unfavorable genetic alterations, limited access to specialized care, and variability in healthcare processes.
Objective:
To evaluate the impact of Electronic Medical Records (EMR) on early mortality among patients with acute leukemia
Methods:
A retrospective cohort study evaluated 274 patients with acute leukemia. Of these, 62% were treated in a traditional physical records (TFR) system and 38% in an EMR system. Data on treatment intensity, time to antibiotic administration, and mortality were analyzed using chi-square, Fisher’s exact tests, and Kaplan-Meier survival analysis.
Results:
Early mortality was significantly lower in the EMR group (5.8%) compared to the TFR group (35.9%, p = 0.000). EMR systems enabled faster responses to critical events like febrile neutropenia, with a median time to antibiotics of 54 minutes versus 272 minutes (p = 0.000). High-intensity regimens were more frequently administered in the EMR group, improving survival outcomes (Log-Rank= 0.000).
Conclusions:
EMR systems reduce mortality and optimize critical care processes. Their implementation in public hospitals is essential to improve outcomes in Latin America, ensuring timely and equitable care. Clinical Trial: Non-applicable
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.